Skip navigation.

Announcing a funding opportunity: TB vaccine accelerator

Publication year: 
2012
Corporate author: 
Bill and Melinda Gates Foundation
Publication details: 
USA, BGMF, 2012
Abstract:

A funding proposal prepared by the Bill and Melinda Gates Foundation for the prevention of tuberculosis (TB) through the development and deployment of an effective vaccine. With the assistance and support of the TB research and development community, a set of obstacles to TB vaccine development—and integrated goals that, collectively, could help to directly understand, overcome or work around these obstacles—have been selected. Through a research program focused on achieving this defined set of interdependent goals, the TB Vaccine Accelerator aims to address significant challenges in this field.